Interlink Healthcare Communications

Share this article:
Interlink Healthcare Communications
Interlink Healthcare Communications
(IHC) Group of Companies
989 Lenox Drive, Suite 300
Lawrenceville, NJ 08648
Phone: 609-406-9600 · Fax:609-406-9046
Email: liaquinto@interlinkhc.com · Web: www.interlinkhc.com
Founded: 1996
Parent company: Interpublic Group, New York, N.Y.

Officers: Larry Iaquinto, president.

Healthcare accounts: Bio-Imaging Technologies Inc.; CapMed Personal Health Record; Bristol-Myers Squibb: Avalide, Avapro, Emsam, oncology; Enzon: Depocyte, Oncaspar; GE Healthcare: Adreview, Myoview, Omnipaque, Omniscan, Optison, Visipaque; Merck: Januvia, MK 523A/B; Merck Vaccines: herpes zoster vaccine; Novartis: Myfortic, Neoral, Sandostatin, Simulect, Zometa; Organon: NuvaRing; Pfizer: PF-3512676; sanofi-aventis: Avalide, Avapro.

Accounts gained (7): Merck: Januvia (medical education), MK524 A/B (medical education); Merck Vaccines: herpes zoster vaccine (medical education); Pfizer: PF-3512676 (promotional AOR); Enzon: Depocyte (promotional AOR), Oncaspar (promotional AOR); Organon: global.

Accounts lost (1): Bristol-Myers Squibb: Pravachol (patent expiration); Novartis: Gleevec (account resigned); Bayer Healthcare: BAY 43-9006 (lost).

Services: Full-service healthcare advertising and promotion agency with comprehensive scientific communications and medical education capabilities. Specific capabilities include global branding, affiliate communication, sales force promotion, professional advertising, DTC/DTP, e-solutions, interactive media, video production, sales meetings, exhibit design/convention activities, advocate development, publication planning, speakers’ bureaus, patient education.

Divisions: Interlink Healthcare Communications, IneXel Medical Strategy and Communications.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Agency

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.